(Q30678072)

19 October 2017

Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data (English)

1 reference

acute promyelocytic leukemia

19 October 2017

1 reference

1 reference

1 reference

1

1 reference

19 October 2017

2

Hagop Kantarjian

1 reference

19 October 2017

5

Jorge Cortes

1 reference

19 October 2017

7

Farhad Ravandi

1 reference

19 October 2017

4

Sherry Pierce

1 reference

19 October 2017

3

Elihu Estey

1 reference

19 October 2017

Gabriel Lopez-Berestein

series ordinal

6

object named as

Gabriel Lopez-Berestein

1 reference

19 October 2017

language of work or name

English

0 references

publication date

12 October 2013

1 reference

Clinical Lymphoma, Myeloma & Leukemia

19 October 2017

1 reference

19 October 2017

14

1 reference

19 October 2017

1

1 reference

19 October 2017

e47-9

1 reference

How to manage acute promyelocytic leukemia

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4103408

Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24128595

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CLML.2013.08.004

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

24128595

1 reference